Nilotinib vs Everolimus

Interacting Drugs
Nilotinib
vs
Everolimus
Security Level
Moderate, Consider therapy modification
Mechanism
Everolimus: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Everolimus.
Management
Everolimus dose reductions are required for patients being treated for subependymal giant cell astrocytoma or renal cell carcinoma. See prescribing information for specific dose adjustment and monitoring recommendations.

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Nilotinib vs Everolimus


Other Interactions of Nilotinib

We are Developing Our database, More results coming soon.